Advanced Medical Solutions Releases Annual Report and Announces AGM

Advanced Medical Solutions ( (GB:AMS) ) has provided an update.

Advanced Medical Solutions Group plc has released its Annual Report and Accounts for the year ending December 31, 2024, and announced its Annual General Meeting scheduled for June 30, 2025. The report is accessible on the company’s website, and the AGM will take place in London. This announcement underscores AMS’s commitment to transparency and shareholder engagement, potentially strengthening its market position and stakeholder confidence.

The most recent analyst rating on (GB:AMS) stock is a Buy with a £2.45 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Outperform.

Advanced Medical Solutions receives a solid score due to strong revenue growth and positive corporate developments. However, high valuation metrics and declining profitability margins slightly temper the outlook. Technical indicators suggest stable momentum, supporting the overall positive sentiment.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc (AMS) is a leading developer and manufacturer of innovative tissue-healing technologies, offering a range of surgical products such as tissue adhesives, sutures, haemostats, and internal fixation devices. The company also provides wound care dressings under its ActivHeal brand and has expanded through multiple acquisitions since 2019. AMS operates globally with manufacturing sites in several countries and has R&D hubs in the UK, Ireland, Germany, France, and Israel.

Average Trading Volume: 1,047,835

Technical Sentiment Signal: Sell

Current Market Cap: £443.3M

See more data about AMS stock on TipRanks’ Stock Analysis page.